Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM.

Nature. 2004 Aug 5;430(7000):694-9. Epub 2004 Jul 18.

PMID:
15258597
2.

A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.

Heyninck K, Beyaert R.

Trends Biochem Sci. 2005 Jan;30(1):1-4. Review.

PMID:
15653317
3.

ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.

Verstrepen L, Carpentier I, Verhelst K, Beyaert R.

Biochem Pharmacol. 2009 Jul 15;78(2):105-14. doi: 10.1016/j.bcp.2009.02.009. Epub 2009 Feb 27. Review.

PMID:
19464428
4.

Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

Verstrepen L, Verhelst K, van Loo G, Carpentier I, Ley SC, Beyaert R.

Biochem Pharmacol. 2010 Dec 15;80(12):2009-20. doi: 10.1016/j.bcp.2010.06.044. Epub 2010 Jul 3. Review.

PMID:
20599425
5.

A20: from ubiquitin editing to tumour suppression.

Hymowitz SG, Wertz IE.

Nat Rev Cancer. 2010 May;10(5):332-41. doi: 10.1038/nrc2775. Epub 2010 Apr 12. Review.

PMID:
20383180
6.

Deubiquitinases in the regulation of NF-κB signaling.

Harhaj EW, Dixit VM.

Cell Res. 2011 Jan;21(1):22-39. doi: 10.1038/cr.2010.166. Epub 2010 Nov 30. Review.

7.

The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).

Verstrepen L, Carpentier I, Beyaert R.

Adv Exp Med Biol. 2014;809:13-31. Review.

PMID:
25302363
8.

Regulation of NF-κB signaling by the A20 deubiquitinase.

Shembade N, Harhaj EW.

Cell Mol Immunol. 2012 Mar;9(2):123-30. doi: 10.1038/cmi.2011.59. Epub 2012 Feb 20. Review.

9.

The biology of A20-like molecules.

Enesa K, Evans P.

Adv Exp Med Biol. 2014;809:33-48. Review.

PMID:
25302364
10.

TRAF2: a double-edged sword?

Xia ZP, Chen ZJ.

Sci STKE. 2005 Feb 22;2005(272):pe7. Review.

PMID:
15728425
11.

Ubiquitin signalling in the NF-kappaB pathway.

Chen ZJ.

Nat Cell Biol. 2005 Aug;7(8):758-65. Review.

12.

Linear ubiquitination signals in adaptive immune responses.

Ikeda F.

Immunol Rev. 2015 Jul;266(1):222-36. doi: 10.1111/imr.12300. Review.

13.

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.

Vereecke L, Beyaert R, van Loo G.

Trends Immunol. 2009 Aug;30(8):383-91. doi: 10.1016/j.it.2009.05.007. Epub 2009 Jul 28. Review.

PMID:
19643665
14.

Anti-viral tetris: modulation of the innate anti-viral immune response by A20.

Arguello M, Paz S, Ferran C, Moll HP, Hiscott J.

Adv Exp Med Biol. 2014;809:49-64. Review.

PMID:
25302365
15.

Ubiquitin-mediated regulation of TNFR1 signaling.

Wertz IE, Dixit VM.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):313-24. doi: 10.1016/j.cytogfr.2008.04.014. Epub 2008 Jun 2. Review.

PMID:
18515172
16.

A20: linking a complex regulator of ubiquitylation to immunity and human disease.

Ma A, Malynn BA.

Nat Rev Immunol. 2012 Nov;12(11):774-85. doi: 10.1038/nri3313. Epub 2012 Oct 12. Review.

17.

Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation.

Bannon A, Zhang SD, Schock BC, Ennis M.

Med Princ Pract. 2015;24(4):301-10. doi: 10.1159/000381423. Epub 2015 Apr 25. Review.

18.

Linear ubiquitination-mediated NF-κB regulation and its related disorders.

Tokunaga F.

J Biochem. 2013 Oct;154(4):313-23. doi: 10.1093/jb/mvt079. Epub 2013 Aug 21. Review.

PMID:
23969028
19.

CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.

Sun SC.

Cell Death Differ. 2010 Jan;17(1):25-34. doi: 10.1038/cdd.2009.43. Review.

20.

Regulation of NF-κB by deubiquitinases.

Harhaj EW, Dixit VM.

Immunol Rev. 2012 Mar;246(1):107-24. doi: 10.1111/j.1600-065X.2012.01100.x. Review.

Supplemental Content

Support Center